Skip to main content
. 2023 Apr 11;2023(4):CD013873. doi: 10.1002/14651858.CD013873.pub2

3.4. Analysis.

3.4

Comparison 3: High‐ versus standard‐dose strategies for treatment of apnea, Outcome 4: Bronchopulmonary dysplasia/chronic lung disease at 36 weeks' postmenstrual age